Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,377 | 4,340 | N/A | N/A | N/A |
| Depreciation Amortization | 778 | 760 | N/A | N/A | N/A |
| Accounts receivable | 914 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -262 | N/A | N/A | N/A | N/A |
| Other Working Capital | 2,107 | -1,760 | N/A | N/A | N/A |
| Other Operating Activity | -348 | 10 | 0 | 0 | 0 |
| Operating Cash Flow | $813 | $3,350 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,895 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,740 | -2,230 | N/A | N/A | N/A |
| Other Investing Activity | -16 | -12,130 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,652 | $-14,360 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 516 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -1,949 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -960 | 0 | 0 | 0 |
| Financing Cash Flow | $-1,433 | $-960 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 10,713 | 22,680 | N/A | N/A | N/A |
| End Cash Position | 6,441 | 10,710 | N/A | N/A | N/A |
| Net Cash Flow | $-4,272 | $-11,960 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 813 | 3,350 | N/A | N/A | N/A |
| Capital Expenditure | -1,740 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -928 | 3,350 | 0 | 0 | 0 |